ArticleTransplantation and cellular therapy2021

Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era.

Andrew Johnsrud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.